

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 6.01962201 |
| 2 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 5.76476022 |
| 3 | ATP synthesis coupled proton transport (GO:0015986) | 5.53875434 |
| 4 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 5.53875434 |
| 5 | respiratory electron transport chain (GO:0022904) | 5.34113372 |
| 6 | electron transport chain (GO:0022900) | 5.16171062 |
| 7 | aldehyde catabolic process (GO:0046185) | 4.19843467 |
| 8 | inositol phosphate catabolic process (GO:0071545) | 3.99138499 |
| 9 | protein complex biogenesis (GO:0070271) | 3.91085700 |
| 10 | peptidyl-histidine modification (GO:0018202) | 3.90860985 |
| 11 | branched-chain amino acid catabolic process (GO:0009083) | 3.83003494 |
| 12 | tryptophan catabolic process (GO:0006569) | 3.81693028 |
| 13 | indole-containing compound catabolic process (GO:0042436) | 3.81693028 |
| 14 | indolalkylamine catabolic process (GO:0046218) | 3.81693028 |
| 15 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.78669236 |
| 16 | NADH dehydrogenase complex assembly (GO:0010257) | 3.78669236 |
| 17 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.78669236 |
| 18 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.74911187 |
| 19 | mannosylation (GO:0097502) | 3.73778740 |
| 20 | aromatic amino acid family catabolic process (GO:0009074) | 3.72146171 |
| 21 | cofactor catabolic process (GO:0051187) | 3.71951654 |
| 22 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 3.63413829 |
| 23 | inositol phosphate dephosphorylation (GO:0046855) | 3.63413829 |
| 24 | cytochrome complex assembly (GO:0017004) | 3.62111845 |
| 25 | lactate metabolic process (GO:0006089) | 3.62027691 |
| 26 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.55530647 |
| 27 | L-phenylalanine catabolic process (GO:0006559) | 3.55530647 |
| 28 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.51091537 |
| 29 | tryptophan metabolic process (GO:0006568) | 3.47220259 |
| 30 | NAD biosynthetic process (GO:0009435) | 3.46485269 |
| 31 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.45745589 |
| 32 | L-phenylalanine metabolic process (GO:0006558) | 3.45745589 |
| 33 | proteasome assembly (GO:0043248) | 3.45667116 |
| 34 | cellular biogenic amine catabolic process (GO:0042402) | 3.42795109 |
| 35 | amine catabolic process (GO:0009310) | 3.42795109 |
| 36 | intraciliary transport (GO:0042073) | 3.42224770 |
| 37 | protein-cofactor linkage (GO:0018065) | 3.39101651 |
| 38 | positive regulation of protein homodimerization activity (GO:0090073) | 3.34382811 |
| 39 | DNA double-strand break processing (GO:0000729) | 3.33946866 |
| 40 | auditory receptor cell differentiation (GO:0042491) | 3.32198826 |
| 41 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.31885643 |
| 42 | platelet dense granule organization (GO:0060155) | 3.31553771 |
| 43 | respiratory chain complex IV assembly (GO:0008535) | 3.31518131 |
| 44 | preassembly of GPI anchor in ER membrane (GO:0016254) | 3.29420645 |
| 45 | chaperone-mediated protein transport (GO:0072321) | 3.28517700 |
| 46 | regulation of cilium movement (GO:0003352) | 3.26785459 |
| 47 | signal peptide processing (GO:0006465) | 3.22041243 |
| 48 | GPI anchor biosynthetic process (GO:0006506) | 3.18400184 |
| 49 | epithelial cilium movement (GO:0003351) | 3.17444235 |
| 50 | protein localization to cilium (GO:0061512) | 3.17387609 |
| 51 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.15850260 |
| 52 | coenzyme catabolic process (GO:0009109) | 3.15750787 |
| 53 | protein neddylation (GO:0045116) | 3.15261649 |
| 54 | dopamine transport (GO:0015872) | 3.14716015 |
| 55 | oxidative phosphorylation (GO:0006119) | 3.12858579 |
| 56 | NAD metabolic process (GO:0019674) | 3.12251803 |
| 57 | superoxide anion generation (GO:0042554) | 3.11731371 |
| 58 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.11444412 |
| 59 | C-terminal protein lipidation (GO:0006501) | 3.10113567 |
| 60 | hydrogen ion transmembrane transport (GO:1902600) | 3.09813119 |
| 61 | polyol catabolic process (GO:0046174) | 3.09778058 |
| 62 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.08231609 |
| 63 | ATP biosynthetic process (GO:0006754) | 3.05808984 |
| 64 | kynurenine metabolic process (GO:0070189) | 3.05561226 |
| 65 | rRNA modification (GO:0000154) | 3.04937641 |
| 66 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.03947471 |
| 67 | GPI anchor metabolic process (GO:0006505) | 3.03625619 |
| 68 | synapsis (GO:0007129) | 3.02630277 |
| 69 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.98490774 |
| 70 | proton transport (GO:0015992) | 2.97496243 |
| 71 | hydrogen transport (GO:0006818) | 2.93952316 |
| 72 | indolalkylamine metabolic process (GO:0006586) | 2.93253168 |
| 73 | C-terminal protein amino acid modification (GO:0018410) | 2.91938196 |
| 74 | aerobic respiration (GO:0009060) | 2.88908911 |
| 75 | regulation of mitochondrial translation (GO:0070129) | 2.87176327 |
| 76 | aromatic amino acid family metabolic process (GO:0009072) | 2.85767762 |
| 77 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 2.85249680 |
| 78 | branched-chain amino acid metabolic process (GO:0009081) | 2.84832613 |
| 79 | NADH metabolic process (GO:0006734) | 2.83633302 |
| 80 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.81709625 |
| 81 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.80605200 |
| 82 | bile acid biosynthetic process (GO:0006699) | 2.80301586 |
| 83 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 2.79696662 |
| 84 | cellular ketone body metabolic process (GO:0046950) | 2.78395706 |
| 85 | opsonization (GO:0008228) | 2.78084776 |
| 86 | intracellular protein transmembrane import (GO:0044743) | 2.77750139 |
| 87 | lipid particle organization (GO:0034389) | 2.77616690 |
| 88 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.77001218 |
| 89 | pseudouridine synthesis (GO:0001522) | 2.75931032 |
| 90 | glyoxylate metabolic process (GO:0046487) | 2.75621468 |
| 91 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 2.74720238 |
| 92 | pyridine nucleotide biosynthetic process (GO:0019363) | 2.74720238 |
| 93 | replication fork processing (GO:0031297) | 2.73818708 |
| 94 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 2.73149704 |
| 95 | negative regulation of neurological system process (GO:0031645) | 2.73058243 |
| 96 | phagosome maturation (GO:0090382) | 2.72738489 |
| 97 | regulation of cholesterol esterification (GO:0010872) | 2.72609194 |
| 98 | high-density lipoprotein particle remodeling (GO:0034375) | 2.71703660 |
| 99 | DNA deamination (GO:0045006) | 2.71492929 |
| 100 | nucleotide transmembrane transport (GO:1901679) | 2.69480651 |
| 101 | peroxisome fission (GO:0016559) | 2.69417375 |
| 102 | insulin secretion (GO:0030073) | 2.69169397 |
| 103 | presynaptic membrane assembly (GO:0097105) | 2.67489062 |
| 104 | tricarboxylic acid cycle (GO:0006099) | 2.67382375 |
| 105 | amino acid salvage (GO:0043102) | 2.67107582 |
| 106 | L-methionine salvage (GO:0071267) | 2.67107582 |
| 107 | L-methionine biosynthetic process (GO:0071265) | 2.67107582 |
| 108 | cellular response to zinc ion (GO:0071294) | 2.67031726 |
| 109 | S-adenosylmethionine metabolic process (GO:0046500) | 2.66764089 |
| 110 | inner mitochondrial membrane organization (GO:0007007) | 2.66584473 |
| 111 | protein deneddylation (GO:0000338) | 2.65565695 |
| 112 | dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 2.65058778 |
| 113 | prenylation (GO:0097354) | 2.63790128 |
| 114 | protein prenylation (GO:0018342) | 2.63790128 |
| 115 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.63629180 |
| 116 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.61026773 |
| 117 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.61026773 |
| 118 | cullin deneddylation (GO:0010388) | 2.60810102 |
| 119 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.59994402 |
| 120 | reactive oxygen species biosynthetic process (GO:1903409) | 2.59840765 |
| 121 | cilium morphogenesis (GO:0060271) | 2.58961683 |
| 122 | rRNA methylation (GO:0031167) | 2.58820048 |
| 123 | aggressive behavior (GO:0002118) | 2.58241988 |
| 124 | cellular respiration (GO:0045333) | 2.58082563 |
| 125 | neuron cell-cell adhesion (GO:0007158) | 2.55353075 |
| 126 | glycolipid biosynthetic process (GO:0009247) | 2.54459512 |
| 127 | arginine metabolic process (GO:0006525) | 2.53965414 |
| 128 | regulation of fibrinolysis (GO:0051917) | 2.53510959 |
| 129 | histone H2A acetylation (GO:0043968) | 2.52640598 |
| 130 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.52148482 |
| 131 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.52148482 |
| 132 | nitrogen cycle metabolic process (GO:0071941) | 2.50748159 |
| 133 | axoneme assembly (GO:0035082) | 2.49960231 |
| 134 | somatic diversification of immunoglobulins involved in immune response (GO:0002208) | 2.49608588 |
| 135 | isotype switching (GO:0045190) | 2.49608588 |
| 136 | somatic recombination of immunoglobulin genes involved in immune response (GO:0002204) | 2.49608588 |
| 137 | positive regulation of glycolytic process (GO:0045821) | 2.49502671 |
| 138 | oxaloacetate metabolic process (GO:0006107) | 2.48710122 |
| 139 | regulation of hexokinase activity (GO:1903299) | 2.48384689 |
| 140 | regulation of glucokinase activity (GO:0033131) | 2.48384689 |
| 141 | termination of RNA polymerase III transcription (GO:0006386) | 2.47939444 |
| 142 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.47939444 |
| 143 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.47214912 |
| 144 | protein carboxylation (GO:0018214) | 2.47214912 |
| 145 | succinate metabolic process (GO:0006105) | 2.47177257 |
| 146 | positive regulation of mitochondrial fission (GO:0090141) | 2.46851513 |
| 147 | uronic acid metabolic process (GO:0006063) | 2.46678058 |
| 148 | glucuronate metabolic process (GO:0019585) | 2.46678058 |
| 149 | opioid receptor signaling pathway (GO:0038003) | 2.45772921 |
| 150 | tyrosine metabolic process (GO:0006570) | 2.45303097 |
| 151 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.45163623 |
| 152 | urea metabolic process (GO:0019627) | 2.44935118 |
| 153 | urea cycle (GO:0000050) | 2.44935118 |
| 154 | mitochondrial transport (GO:0006839) | 2.43695263 |
| 155 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.43586478 |
| 156 | neuron fate determination (GO:0048664) | 2.43036004 |
| 157 | regulation of cellular respiration (GO:0043457) | 2.42797562 |
| 158 | purine ribonucleotide transport (GO:0015868) | 2.42062209 |
| 159 | response to pheromone (GO:0019236) | 2.41248994 |
| 160 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 2.41044526 |
| 161 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 2.41044526 |
| 162 | indole-containing compound metabolic process (GO:0042430) | 2.40810305 |
| 163 | plasma lipoprotein particle remodeling (GO:0034369) | 2.40438061 |
| 164 | protein-lipid complex remodeling (GO:0034368) | 2.40438061 |
| 165 | macromolecular complex remodeling (GO:0034367) | 2.40438061 |
| 166 | protein peptidyl-prolyl isomerization (GO:0000413) | 2.39332152 |
| 167 | nucleoside triphosphate biosynthetic process (GO:0009142) | 2.38445063 |
| 168 | regulation of triglyceride catabolic process (GO:0010896) | 2.38183154 |
| 169 | ubiquinone biosynthetic process (GO:0006744) | 2.38024565 |
| 170 | serotonin receptor signaling pathway (GO:0007210) | 2.37031927 |
| 171 | ketone body metabolic process (GO:1902224) | 2.36397242 |
| 172 | cellular response to superoxide (GO:0071451) | 2.36362616 |
| 173 | cellular response to oxygen radical (GO:0071450) | 2.36362616 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 5.10836325 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.67052731 |
| 3 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.31556078 |
| 4 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.14982228 |
| 5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.00630486 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.98852674 |
| 7 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.97197701 |
| 8 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.76554966 |
| 9 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.75779239 |
| 10 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.70537520 |
| 11 | VDR_22108803_ChIP-Seq_LS180_Human | 2.63418007 |
| 12 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.54864100 |
| 13 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.50428770 |
| 14 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.38439124 |
| 15 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.32155056 |
| 16 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.29634142 |
| 17 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 2.19740048 |
| 18 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.17544835 |
| 19 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.16190224 |
| 20 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.07126847 |
| 21 | EWS_26573619_Chip-Seq_HEK293_Human | 2.02258797 |
| 22 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.97420840 |
| 23 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.91432860 |
| 24 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.90795914 |
| 25 | P300_19829295_ChIP-Seq_ESCs_Human | 1.89647817 |
| 26 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.79819776 |
| 27 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.72857020 |
| 28 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.70493384 |
| 29 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.70226295 |
| 30 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.69212715 |
| 31 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.66873179 |
| 32 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.66436719 |
| 33 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.66208848 |
| 34 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.65326434 |
| 35 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.64034772 |
| 36 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.63160730 |
| 37 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.61783785 |
| 38 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.61461909 |
| 39 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.60774989 |
| 40 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.60704969 |
| 41 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.56931878 |
| 42 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.56102654 |
| 43 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.55130744 |
| 44 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.54950742 |
| 45 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.54462818 |
| 46 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.54234940 |
| 47 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.53243013 |
| 48 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.53141126 |
| 49 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.52457433 |
| 50 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.52004424 |
| 51 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.51118969 |
| 52 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.50710888 |
| 53 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.50676047 |
| 54 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.49818338 |
| 55 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.48837583 |
| 56 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.47103505 |
| 57 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.46938298 |
| 58 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.45972231 |
| 59 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.45281629 |
| 60 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.43056717 |
| 61 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.42865593 |
| 62 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.42667867 |
| 63 | FUS_26573619_Chip-Seq_HEK293_Human | 1.42290953 |
| 64 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.41988478 |
| 65 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.41276027 |
| 66 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.41059402 |
| 67 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.41035981 |
| 68 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.40465309 |
| 69 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.40160736 |
| 70 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.38876374 |
| 71 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.37022284 |
| 72 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.36653853 |
| 73 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.35451241 |
| 74 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.34470673 |
| 75 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.34377785 |
| 76 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.33431784 |
| 77 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.32387328 |
| 78 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.31953182 |
| 79 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.30414128 |
| 80 | JUN_21703547_ChIP-Seq_K562_Human | 1.28697817 |
| 81 | PU1_27457419_Chip-Seq_LIVER_Mouse | 1.27501611 |
| 82 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.27493231 |
| 83 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.25991815 |
| 84 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 1.25403304 |
| 85 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.25030870 |
| 86 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.24676861 |
| 87 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.23688508 |
| 88 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.22869999 |
| 89 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 1.22326181 |
| 90 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.18079341 |
| 91 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.17963240 |
| 92 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.17943481 |
| 93 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.17805315 |
| 94 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.17411889 |
| 95 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.16552820 |
| 96 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.16221047 |
| 97 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.16221047 |
| 98 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.15555797 |
| 99 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.15358814 |
| 100 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 1.14371889 |
| 101 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 1.13925668 |
| 102 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.13868905 |
| 103 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.13509423 |
| 104 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.13471551 |
| 105 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.13387096 |
| 106 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.13207355 |
| 107 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.13167312 |
| 108 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.12954015 |
| 109 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.12700547 |
| 110 | AR_20517297_ChIP-Seq_VCAP_Human | 1.12682843 |
| 111 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.10949741 |
| 112 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.10596006 |
| 113 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.10514284 |
| 114 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.10514284 |
| 115 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.10226809 |
| 116 | AR_25329375_ChIP-Seq_VCAP_Human | 1.08385478 |
| 117 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.08349086 |
| 118 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.07973153 |
| 119 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.07971181 |
| 120 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.07320146 |
| 121 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.05921440 |
| 122 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.05009444 |
| 123 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.02317098 |
| 124 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.02241434 |
| 125 | NCOR_22424771_ChIP-Seq_293T_Human | 1.00847350 |
| 126 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.00271681 |
| 127 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.99638926 |
| 128 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.99090476 |
| 129 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.98892230 |
| 130 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.97872712 |
| 131 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.97872712 |
| 132 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.97300005 |
| 133 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.97144200 |
| 134 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.96162105 |
| 135 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.95268448 |
| 136 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.94719391 |
| 137 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.94133659 |
| 138 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.93115191 |
| 139 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.93034663 |
| 140 | KDM2B_26808549_Chip-Seq_REH_Human | 0.92865596 |
| 141 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.92803410 |
| 142 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.89287449 |
| 143 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.87954550 |
| 144 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.87894430 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 4.18702876 |
| 2 | MP0005360_urolithiasis | 4.02518405 |
| 3 | MP0003880_abnormal_central_pattern | 3.79174280 |
| 4 | MP0003806_abnormal_nucleotide_metabolis | 3.75004356 |
| 5 | MP0005085_abnormal_gallbladder_physiolo | 3.41432742 |
| 6 | MP0006072_abnormal_retinal_apoptosis | 3.20339931 |
| 7 | MP0003195_calcinosis | 2.88821499 |
| 8 | MP0009697_abnormal_copulation | 2.68153725 |
| 9 | MP0005365_abnormal_bile_salt | 2.60340212 |
| 10 | MP0008875_abnormal_xenobiotic_pharmacok | 2.56358173 |
| 11 | MP0006276_abnormal_autonomic_nervous | 2.55658255 |
| 12 | MP0002736_abnormal_nociception_after | 2.45869089 |
| 13 | MP0002938_white_spotting | 2.29657847 |
| 14 | MP0001968_abnormal_touch/_nociception | 2.24513741 |
| 15 | MP0001529_abnormal_vocalization | 2.14462051 |
| 16 | MP0002735_abnormal_chemical_nociception | 2.12270937 |
| 17 | MP0002876_abnormal_thyroid_physiology | 2.11503223 |
| 18 | MP0005253_abnormal_eye_physiology | 2.10017351 |
| 19 | MP0008058_abnormal_DNA_repair | 2.06971673 |
| 20 | MP0006036_abnormal_mitochondrial_physio | 2.06389685 |
| 21 | MP0006035_abnormal_mitochondrial_morpho | 1.99351091 |
| 22 | MP0003787_abnormal_imprinting | 1.96316966 |
| 23 | MP0003186_abnormal_redox_activity | 1.83470911 |
| 24 | MP0003122_maternal_imprinting | 1.79668796 |
| 25 | MP0008789_abnormal_olfactory_epithelium | 1.79112155 |
| 26 | MP0002837_dystrophic_cardiac_calcinosis | 1.73981086 |
| 27 | MP0008877_abnormal_DNA_methylation | 1.73066160 |
| 28 | MP0001905_abnormal_dopamine_level | 1.67593195 |
| 29 | MP0003724_increased_susceptibility_to | 1.67212557 |
| 30 | MP0009046_muscle_twitch | 1.66011199 |
| 31 | MP0009780_abnormal_chondrocyte_physiolo | 1.62250480 |
| 32 | MP0001764_abnormal_homeostasis | 1.60874109 |
| 33 | MP0001835_abnormal_antigen_presentation | 1.60555165 |
| 34 | MP0009745_abnormal_behavioral_response | 1.60187474 |
| 35 | MP0004147_increased_porphyrin_level | 1.57505880 |
| 36 | MP0001984_abnormal_olfaction | 1.57358545 |
| 37 | MP0005332_abnormal_amino_acid | 1.56934421 |
| 38 | MP0010329_abnormal_lipoprotein_level | 1.55209453 |
| 39 | MP0001485_abnormal_pinna_reflex | 1.54457203 |
| 40 | MP0005187_abnormal_penis_morphology | 1.54045743 |
| 41 | MP0005367_renal/urinary_system_phenotyp | 1.54022236 |
| 42 | MP0000516_abnormal_urinary_system | 1.54022236 |
| 43 | MP0002272_abnormal_nervous_system | 1.51133120 |
| 44 | MP0004142_abnormal_muscle_tone | 1.49038580 |
| 45 | MP0002064_seizures | 1.48670144 |
| 46 | MP0005083_abnormal_biliary_tract | 1.48207197 |
| 47 | MP0003646_muscle_fatigue | 1.47529375 |
| 48 | MP0010234_abnormal_vibrissa_follicle | 1.45622394 |
| 49 | MP0004215_abnormal_myocardial_fiber | 1.41427010 |
| 50 | MP0003252_abnormal_bile_duct | 1.40611579 |
| 51 | MP0001188_hyperpigmentation | 1.40254471 |
| 52 | MP0000647_abnormal_sebaceous_gland | 1.40236884 |
| 53 | MP0006082_CNS_inflammation | 1.39399937 |
| 54 | MP0004133_heterotaxia | 1.39395550 |
| 55 | MP0003786_premature_aging | 1.38263237 |
| 56 | MP0000013_abnormal_adipose_tissue | 1.37126363 |
| 57 | MP0002148_abnormal_hypersensitivity_rea | 1.36765128 |
| 58 | MP0002572_abnormal_emotion/affect_behav | 1.35526725 |
| 59 | MP0002138_abnormal_hepatobiliary_system | 1.34283738 |
| 60 | MP0002332_abnormal_exercise_endurance | 1.33869305 |
| 61 | MP0005220_abnormal_exocrine_pancreas | 1.33653267 |
| 62 | MP0002160_abnormal_reproductive_system | 1.32759764 |
| 63 | MP0009785_altered_susceptibility_to | 1.32510578 |
| 64 | MP0002090_abnormal_vision | 1.31940469 |
| 65 | MP0002234_abnormal_pharynx_morphology | 1.31368100 |
| 66 | MP0001944_abnormal_pancreas_morphology | 1.29192152 |
| 67 | MP0008260_abnormal_autophagy | 1.27288747 |
| 68 | MP0003121_genomic_imprinting | 1.26546424 |
| 69 | MP0005174_abnormal_tail_pigmentation | 1.25099112 |
| 70 | MP0003635_abnormal_synaptic_transmissio | 1.24161095 |
| 71 | MP0005535_abnormal_body_temperature | 1.23756375 |
| 72 | MP0002638_abnormal_pupillary_reflex | 1.22788864 |
| 73 | MP0005499_abnormal_olfactory_system | 1.22667310 |
| 74 | MP0005394_taste/olfaction_phenotype | 1.22667310 |
| 75 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.21978878 |
| 76 | MP0002067_abnormal_sensory_capabilities | 1.20629106 |
| 77 | MP0002063_abnormal_learning/memory/cond | 1.18886857 |
| 78 | MP0002254_reproductive_system_inflammat | 1.18575797 |
| 79 | MP0005084_abnormal_gallbladder_morpholo | 1.17622634 |
| 80 | MP0002693_abnormal_pancreas_physiology | 1.16708621 |
| 81 | MP0009764_decreased_sensitivity_to | 1.16288645 |
| 82 | MP0005248_abnormal_Harderian_gland | 1.16139146 |
| 83 | MP0000631_abnormal_neuroendocrine_gland | 1.15438440 |
| 84 | MP0000427_abnormal_hair_cycle | 1.15432678 |
| 85 | MP0005266_abnormal_metabolism | 1.15419714 |
| 86 | MP0002734_abnormal_mechanical_nocicepti | 1.14423606 |
| 87 | MP0005671_abnormal_response_to | 1.13838772 |
| 88 | MP0005171_absent_coat_pigmentation | 1.13695747 |
| 89 | MP0002928_abnormal_bile_duct | 1.13298481 |
| 90 | MP0001986_abnormal_taste_sensitivity | 1.12994279 |
| 91 | MP0000538_abnormal_urinary_bladder | 1.12667016 |
| 92 | MP0001486_abnormal_startle_reflex | 1.12277066 |
| 93 | MP0010386_abnormal_urinary_bladder | 1.11563763 |
| 94 | MP0001756_abnormal_urination | 1.10846510 |
| 95 | MP0001440_abnormal_grooming_behavior | 1.10388026 |
| 96 | MP0003436_decreased_susceptibility_to | 1.10232233 |
| 97 | MP0004924_abnormal_behavior | 1.08769579 |
| 98 | MP0005386_behavior/neurological_phenoty | 1.08769579 |
| 99 | MP0005451_abnormal_body_composition | 1.08167042 |
| 100 | MP0009379_abnormal_foot_pigmentation | 1.07885097 |
| 101 | MP0005376_homeostasis/metabolism_phenot | 1.07791403 |
| 102 | MP0006054_spinal_hemorrhage | 1.07693899 |
| 103 | MP0001501_abnormal_sleep_pattern | 1.05770436 |
| 104 | MP0002277_abnormal_respiratory_mucosa | 1.04393735 |
| 105 | MP0003656_abnormal_erythrocyte_physiolo | 1.03880280 |
| 106 | MP0008775_abnormal_heart_ventricle | 1.03726272 |
| 107 | MP0002233_abnormal_nose_morphology | 1.03142142 |
| 108 | MP0005075_abnormal_melanosome_morpholog | 1.02423107 |
| 109 | MP0002102_abnormal_ear_morphology | 1.00249146 |
| 110 | MP0003136_yellow_coat_color | 0.99527290 |
| 111 | MP0004134_abnormal_chest_morphology | 0.99316198 |
| 112 | MP0002751_abnormal_autonomic_nervous | 0.98883593 |
| 113 | MP0005391_vision/eye_phenotype | 0.98104603 |
| 114 | MP0005389_reproductive_system_phenotype | 0.97649234 |
| 115 | MP0003191_abnormal_cellular_cholesterol | 0.96935061 |
| 116 | MP0004019_abnormal_vitamin_homeostasis | 0.96742464 |
| 117 | MP0001293_anophthalmia | 0.96578502 |
| 118 | MP0003315_abnormal_perineum_morphology | 0.96044053 |
| 119 | MP0002118_abnormal_lipid_homeostasis | 0.95108488 |
| 120 | MP0004885_abnormal_endolymph | 0.95040781 |
| 121 | MP0003011_delayed_dark_adaptation | 0.95022718 |
| 122 | MP0002909_abnormal_adrenal_gland | 0.94297606 |
| 123 | MP0002419_abnormal_innate_immunity | 0.93285365 |
| 124 | MP0004270_analgesia | 0.93239158 |
| 125 | MP0006292_abnormal_olfactory_placode | 0.93044924 |
| 126 | MP0005000_abnormal_immune_tolerance | 0.91879353 |
| 127 | MP0008469_abnormal_protein_level | 0.90732466 |
| 128 | MP0001661_extended_life_span | 0.89917934 |
| 129 | MP0005319_abnormal_enzyme/_coenzyme | 0.89447165 |
| 130 | MP0002653_abnormal_ependyma_morphology | 0.88125099 |
| 131 | MP0000372_irregular_coat_pigmentation | 0.87074680 |
| 132 | MP0000639_abnormal_adrenal_gland | 0.85655568 |
| 133 | MP0005551_abnormal_eye_electrophysiolog | 0.84404271 |
| 134 | MP0005645_abnormal_hypothalamus_physiol | 0.83285053 |
| 135 | MP0004859_abnormal_synaptic_plasticity | 0.83039921 |
| 136 | MP0005025_abnormal_response_to | 0.82736288 |
| 137 | MP0001929_abnormal_gametogenesis | 0.82064500 |
| 138 | MP0002822_catalepsy | 0.81544130 |
| 139 | MP0002095_abnormal_skin_pigmentation | 0.81262228 |
| 140 | MP0005379_endocrine/exocrine_gland_phen | 0.80111512 |
| 141 | MP0002733_abnormal_thermal_nociception | 0.76713363 |
| 142 | MP0005646_abnormal_pituitary_gland | 0.76708267 |
| 143 | MP0005636_abnormal_mineral_homeostasis | 0.76094219 |
| 144 | MP0000015_abnormal_ear_pigmentation | 0.75933982 |
| 145 | MP0001970_abnormal_pain_threshold | 0.74951053 |
| 146 | MP0010094_abnormal_chromosome_stability | 0.74145987 |
| 147 | MP0008995_early_reproductive_senescence | 0.73242815 |
| 148 | MP0003868_abnormal_feces_composition | 0.72804689 |
| 149 | MP0009840_abnormal_foam_cell | 0.72636413 |
| 150 | MP0002163_abnormal_gland_morphology | 0.72516792 |
| 151 | MP0002132_abnormal_respiratory_system | 0.71830779 |
| 152 | MP0000653_abnormal_sex_gland | 0.71466400 |
| 153 | MP0002295_abnormal_pulmonary_circulatio | 0.70581383 |
| 154 | MP0002078_abnormal_glucose_homeostasis | 0.70415094 |
| 155 | MP0001666_abnormal_nutrient_absorption | 0.68975528 |
| 156 | MP0003718_maternal_effect | 0.68812904 |
| 157 | MP0002184_abnormal_innervation | 0.68187516 |
| 158 | MP0008872_abnormal_physiological_respon | 0.67796780 |
| 159 | MP0000566_synostosis | 0.67690351 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Acute necrotizing encephalopathy (HP:0006965) | 5.84202640 |
| 2 | Abnormal mitochondria in muscle tissue (HP:0008316) | 5.39797756 |
| 3 | Acute encephalopathy (HP:0006846) | 5.08325523 |
| 4 | Progressive macrocephaly (HP:0004481) | 5.08319857 |
| 5 | Mitochondrial inheritance (HP:0001427) | 4.85608926 |
| 6 | Hepatocellular necrosis (HP:0001404) | 4.49885795 |
| 7 | Increased CSF lactate (HP:0002490) | 4.44207040 |
| 8 | Cerebral edema (HP:0002181) | 4.39143829 |
| 9 | Hepatic necrosis (HP:0002605) | 4.24572341 |
| 10 | Increased serum pyruvate (HP:0003542) | 4.14119277 |
| 11 | Abnormality of glycolysis (HP:0004366) | 4.14119277 |
| 12 | Hyperventilation (HP:0002883) | 3.65593706 |
| 13 | 3-Methylglutaconic aciduria (HP:0003535) | 3.56154384 |
| 14 | Prolonged partial thromboplastin time (HP:0003645) | 3.48684065 |
| 15 | True hermaphroditism (HP:0010459) | 3.38834419 |
| 16 | Optic disc pallor (HP:0000543) | 3.31565269 |
| 17 | Lactic acidosis (HP:0003128) | 3.28755130 |
| 18 | Hypobetalipoproteinemia (HP:0003563) | 3.25293952 |
| 19 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.19063608 |
| 20 | Pancreatic cysts (HP:0001737) | 3.15201226 |
| 21 | Increased serum lactate (HP:0002151) | 3.14782256 |
| 22 | Pancreatic fibrosis (HP:0100732) | 3.12520795 |
| 23 | Intestinal atresia (HP:0011100) | 3.07303058 |
| 24 | Respiratory failure (HP:0002878) | 3.06728471 |
| 25 | Renal Fanconi syndrome (HP:0001994) | 3.03534671 |
| 26 | Joint hemorrhage (HP:0005261) | 3.03466631 |
| 27 | Exercise intolerance (HP:0003546) | 3.02837118 |
| 28 | Increased hepatocellular lipid droplets (HP:0006565) | 3.01442724 |
| 29 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.96149123 |
| 30 | Lipid accumulation in hepatocytes (HP:0006561) | 2.95582235 |
| 31 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.90480048 |
| 32 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.90480048 |
| 33 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.89489336 |
| 34 | Conjugated hyperbilirubinemia (HP:0002908) | 2.89373514 |
| 35 | Focal motor seizures (HP:0011153) | 2.88325953 |
| 36 | Lethargy (HP:0001254) | 2.81347428 |
| 37 | Leukodystrophy (HP:0002415) | 2.77747234 |
| 38 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.65625934 |
| 39 | Neuroendocrine neoplasm (HP:0100634) | 2.63004472 |
| 40 | Intrahepatic cholestasis (HP:0001406) | 2.62646638 |
| 41 | Progressive external ophthalmoplegia (HP:0000590) | 2.56508634 |
| 42 | Nephronophthisis (HP:0000090) | 2.56026035 |
| 43 | Ketoacidosis (HP:0001993) | 2.55982411 |
| 44 | Colon cancer (HP:0003003) | 2.51086424 |
| 45 | Increased intramyocellular lipid droplets (HP:0012240) | 2.49956712 |
| 46 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.49143232 |
| 47 | Molar tooth sign on MRI (HP:0002419) | 2.45310304 |
| 48 | Abnormality of midbrain morphology (HP:0002418) | 2.45310304 |
| 49 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.43474309 |
| 50 | Febrile seizures (HP:0002373) | 2.39897331 |
| 51 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.37987092 |
| 52 | Type I transferrin isoform profile (HP:0003642) | 2.36792810 |
| 53 | Abnormality of alanine metabolism (HP:0010916) | 2.35084896 |
| 54 | Hyperalaninemia (HP:0003348) | 2.35084896 |
| 55 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.35084896 |
| 56 | Pheochromocytoma (HP:0002666) | 2.33792062 |
| 57 | Hyperglycinemia (HP:0002154) | 2.33080700 |
| 58 | Abnormality of methionine metabolism (HP:0010901) | 2.32207374 |
| 59 | Microvesicular hepatic steatosis (HP:0001414) | 2.31617424 |
| 60 | Abnormal protein glycosylation (HP:0012346) | 2.31488431 |
| 61 | Abnormal glycosylation (HP:0012345) | 2.31488431 |
| 62 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.31488431 |
| 63 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.31488431 |
| 64 | Sclerocornea (HP:0000647) | 2.29198289 |
| 65 | Methylmalonic aciduria (HP:0012120) | 2.28345112 |
| 66 | Tubulointerstitial nephritis (HP:0001970) | 2.24155585 |
| 67 | Hyperammonemia (HP:0001987) | 2.22449389 |
| 68 | Systemic lupus erythematosus (HP:0002725) | 2.22405724 |
| 69 | Increased muscle lipid content (HP:0009058) | 2.21826999 |
| 70 | X-linked dominant inheritance (HP:0001423) | 2.21062427 |
| 71 | Male pseudohermaphroditism (HP:0000037) | 2.20408954 |
| 72 | Chronic hepatic failure (HP:0100626) | 2.17682393 |
| 73 | Abnormality of vitamin B metabolism (HP:0004340) | 2.17501574 |
| 74 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.17340307 |
| 75 | Increased IgM level (HP:0003496) | 2.15797590 |
| 76 | Exertional dyspnea (HP:0002875) | 2.15294699 |
| 77 | Vomiting (HP:0002013) | 2.14219195 |
| 78 | Septo-optic dysplasia (HP:0100842) | 2.12618257 |
| 79 | Furrowed tongue (HP:0000221) | 2.10989060 |
| 80 | CNS demyelination (HP:0007305) | 2.10647510 |
| 81 | Poor head control (HP:0002421) | 2.10609030 |
| 82 | Fair hair (HP:0002286) | 2.09660656 |
| 83 | Abnormality of serum amino acid levels (HP:0003112) | 2.08428872 |
| 84 | Epileptic encephalopathy (HP:0200134) | 2.08002141 |
| 85 | Abnormality of the renal medulla (HP:0100957) | 2.07696598 |
| 86 | Metabolic acidosis (HP:0001942) | 2.06329326 |
| 87 | Glycosuria (HP:0003076) | 2.06190266 |
| 88 | Abnormality of urine glucose concentration (HP:0011016) | 2.06190266 |
| 89 | Ketosis (HP:0001946) | 2.05557290 |
| 90 | Hyperglycinuria (HP:0003108) | 2.04619108 |
| 91 | Medial flaring of the eyebrow (HP:0010747) | 2.04070414 |
| 92 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.03968121 |
| 93 | Epidermoid cyst (HP:0200040) | 2.03453172 |
| 94 | Xanthomatosis (HP:0000991) | 2.03058961 |
| 95 | Abnormality of renal resorption (HP:0011038) | 2.02434259 |
| 96 | Genital tract atresia (HP:0001827) | 2.02073972 |
| 97 | Hyperlipoproteinemia (HP:0010980) | 2.00239634 |
| 98 | Vaginal atresia (HP:0000148) | 2.00220277 |
| 99 | Atonic seizures (HP:0010819) | 1.99925775 |
| 100 | Nausea (HP:0002018) | 1.98578435 |
| 101 | Renal cortical cysts (HP:0000803) | 1.98117823 |
| 102 | Abnormal pupillary function (HP:0007686) | 1.97350749 |
| 103 | Abnormal hair whorl (HP:0010721) | 1.95740578 |
| 104 | Hyperbilirubinemia (HP:0002904) | 1.95716865 |
| 105 | Hypolipoproteinemia (HP:0010981) | 1.95555543 |
| 106 | Optic neuritis (HP:0100653) | 1.95548515 |
| 107 | Retrobulbar optic neuritis (HP:0100654) | 1.95548515 |
| 108 | Adrenal hypoplasia (HP:0000835) | 1.95453161 |
| 109 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.94868788 |
| 110 | Abnormality of glycine metabolism (HP:0010895) | 1.94868788 |
| 111 | Hemiparesis (HP:0001269) | 1.94157497 |
| 112 | Type II lissencephaly (HP:0007260) | 1.93248038 |
| 113 | Optic nerve hypoplasia (HP:0000609) | 1.93124268 |
| 114 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.93115706 |
| 115 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.93115706 |
| 116 | Abnormal biliary tract physiology (HP:0012439) | 1.92856536 |
| 117 | Bile duct proliferation (HP:0001408) | 1.92856536 |
| 118 | Methylmalonic acidemia (HP:0002912) | 1.91661296 |
| 119 | Acute hepatic failure (HP:0006554) | 1.91545426 |
| 120 | Complement deficiency (HP:0004431) | 1.91410712 |
| 121 | Supernumerary spleens (HP:0009799) | 1.91280970 |
| 122 | Double outlet right ventricle (HP:0001719) | 1.90548446 |
| 123 | Congenital malformation of the right heart (HP:0011723) | 1.90548446 |
| 124 | Cystic liver disease (HP:0006706) | 1.88674159 |
| 125 | Abnormality of the renal cortex (HP:0011035) | 1.87995128 |
| 126 | Parakeratosis (HP:0001036) | 1.85868921 |
| 127 | Hyperglycemia (HP:0003074) | 1.85864909 |
| 128 | Hypothermia (HP:0002045) | 1.85466332 |
| 129 | Hypoglycemic seizures (HP:0002173) | 1.83719291 |
| 130 | Fat malabsorption (HP:0002630) | 1.82213842 |
| 131 | Myokymia (HP:0002411) | 1.81505043 |
| 132 | Deep venous thrombosis (HP:0002625) | 1.80543247 |
| 133 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.80167606 |
| 134 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.79731966 |
| 135 | Occipital encephalocele (HP:0002085) | 1.78633168 |
| 136 | Hypophosphatemic rickets (HP:0004912) | 1.78593802 |
| 137 | Respiratory difficulties (HP:0002880) | 1.78229922 |
| 138 | Gliosis (HP:0002171) | 1.78194971 |
| 139 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.77134837 |
| 140 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.76737457 |
| 141 | Decreased testicular size (HP:0008734) | 1.74785655 |
| 142 | Median cleft lip (HP:0000161) | 1.74516814 |
| 143 | Postaxial hand polydactyly (HP:0001162) | 1.73961913 |
| 144 | Hypoglycemic coma (HP:0001325) | 1.71978895 |
| 145 | Gait imbalance (HP:0002141) | 1.71918028 |
| 146 | Nephrogenic diabetes insipidus (HP:0009806) | 1.71593642 |
| 147 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.70894344 |
| 148 | Dicarboxylic aciduria (HP:0003215) | 1.70894344 |
| 149 | Stomatitis (HP:0010280) | 1.70726793 |
| 150 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.70479261 |
| 151 | Hypoalbuminemia (HP:0003073) | 1.70440134 |
| 152 | Abnormal albumin level (HP:0012116) | 1.70440134 |
| 153 | Blue irides (HP:0000635) | 1.70274719 |
| 154 | Disproportionate short-trunk short stature (HP:0003521) | 1.69794819 |
| 155 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.68522266 |
| 156 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.68277686 |
| 157 | Congenital primary aphakia (HP:0007707) | 1.68199459 |
| 158 | Generalized aminoaciduria (HP:0002909) | 1.67910829 |
| 159 | Absence seizures (HP:0002121) | 1.64090923 |
| 160 | Eczematoid dermatitis (HP:0000976) | 1.63512367 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CASK | 4.38138885 |
| 2 | MAP4K2 | 4.14076508 |
| 3 | TRIM28 | 2.85970805 |
| 4 | MAP3K12 | 2.79658196 |
| 5 | MST4 | 2.75771021 |
| 6 | MAP2K7 | 2.71488888 |
| 7 | WNK3 | 2.69936450 |
| 8 | STK16 | 2.50677828 |
| 9 | MAP3K14 | 2.33115999 |
| 10 | PBK | 2.26450434 |
| 11 | PLK2 | 2.14458286 |
| 12 | EIF2AK1 | 2.01297197 |
| 13 | ARAF | 1.97894444 |
| 14 | TXK | 1.97262732 |
| 15 | ZAK | 1.93546820 |
| 16 | RIPK4 | 1.92720257 |
| 17 | IRAK3 | 1.81113552 |
| 18 | NUAK1 | 1.71722063 |
| 19 | BMPR2 | 1.70011122 |
| 20 | MAP3K4 | 1.63646091 |
| 21 | GRK7 | 1.63050272 |
| 22 | NME1 | 1.61124428 |
| 23 | NME2 | 1.57458504 |
| 24 | BRAF | 1.56468075 |
| 25 | BCR | 1.56350680 |
| 26 | NTRK3 | 1.55248422 |
| 27 | FGFR2 | 1.54980077 |
| 28 | SIK3 | 1.54970707 |
| 29 | CSNK1G1 | 1.53840648 |
| 30 | PDK2 | 1.49300063 |
| 31 | AKT3 | 1.46619607 |
| 32 | MYLK | 1.46592620 |
| 33 | YES1 | 1.42702124 |
| 34 | TAOK2 | 1.35741763 |
| 35 | IRAK4 | 1.34110405 |
| 36 | NEK1 | 1.30919326 |
| 37 | STK39 | 1.23524064 |
| 38 | PHKG2 | 1.23365550 |
| 39 | PHKG1 | 1.23365550 |
| 40 | PRPF4B | 1.23247369 |
| 41 | MAP2K4 | 1.21916474 |
| 42 | KDR | 1.21535199 |
| 43 | MKNK2 | 1.20453104 |
| 44 | CSNK1G2 | 1.19101714 |
| 45 | SRPK1 | 1.16984625 |
| 46 | INSRR | 1.16891463 |
| 47 | BLK | 1.16844993 |
| 48 | CSNK1A1L | 1.16744386 |
| 49 | EIF2AK3 | 1.15928478 |
| 50 | ADRBK2 | 1.15683532 |
| 51 | ABL2 | 1.14282042 |
| 52 | PDK3 | 1.14099229 |
| 53 | PDK4 | 1.14099229 |
| 54 | ERBB4 | 1.12903219 |
| 55 | WNK4 | 1.10074579 |
| 56 | PIM2 | 1.09701479 |
| 57 | MKNK1 | 1.09454346 |
| 58 | TAOK3 | 1.06914348 |
| 59 | NEK9 | 1.06450517 |
| 60 | MARK1 | 1.06330146 |
| 61 | BCKDK | 1.05593566 |
| 62 | MINK1 | 1.03651274 |
| 63 | STK38L | 1.01236839 |
| 64 | EPHA4 | 1.00866358 |
| 65 | MAP3K13 | 0.99536455 |
| 66 | LIMK1 | 0.97644736 |
| 67 | MAPK13 | 0.97606424 |
| 68 | PAK3 | 0.97022653 |
| 69 | TLK1 | 0.96950472 |
| 70 | BUB1 | 0.95946112 |
| 71 | OBSCN | 0.95082567 |
| 72 | SCYL2 | 0.94666423 |
| 73 | BMPR1B | 0.93766309 |
| 74 | PLK4 | 0.92469052 |
| 75 | PRKCG | 0.90609326 |
| 76 | CAMK2A | 0.89760156 |
| 77 | ERBB3 | 0.89102108 |
| 78 | ACVR1B | 0.88133101 |
| 79 | EIF2AK2 | 0.86400377 |
| 80 | PINK1 | 0.84089807 |
| 81 | FER | 0.83854466 |
| 82 | DYRK3 | 0.83488024 |
| 83 | FLT3 | 0.82306524 |
| 84 | RPS6KA4 | 0.79048981 |
| 85 | GRK5 | 0.77677965 |
| 86 | PNCK | 0.76834179 |
| 87 | PRKCE | 0.76492091 |
| 88 | PRKCQ | 0.75500007 |
| 89 | FRK | 0.75386161 |
| 90 | VRK2 | 0.75368096 |
| 91 | CAMK2B | 0.75216266 |
| 92 | DYRK2 | 0.74603722 |
| 93 | BRSK2 | 0.74082620 |
| 94 | SGK2 | 0.73704463 |
| 95 | CCNB1 | 0.72713288 |
| 96 | PLK1 | 0.71977721 |
| 97 | CAMK2G | 0.70842882 |
| 98 | NEK6 | 0.67492923 |
| 99 | SYK | 0.67114643 |
| 100 | IRAK2 | 0.64851301 |
| 101 | PIK3CG | 0.64382535 |
| 102 | ILK | 0.63111197 |
| 103 | PIK3CA | 0.60926038 |
| 104 | OXSR1 | 0.58744973 |
| 105 | STK3 | 0.58705040 |
| 106 | RPS6KA5 | 0.57006659 |
| 107 | FES | 0.56602179 |
| 108 | TESK1 | 0.56062800 |
| 109 | PKN1 | 0.55655463 |
| 110 | TNIK | 0.55520659 |
| 111 | DAPK1 | 0.54601992 |
| 112 | SGK494 | 0.53164497 |
| 113 | SGK223 | 0.53164497 |
| 114 | MAP3K11 | 0.52692834 |
| 115 | CSNK1A1 | 0.52592940 |
| 116 | LYN | 0.51856157 |
| 117 | MARK3 | 0.50946118 |
| 118 | GRK6 | 0.50148597 |
| 119 | GRK1 | 0.50136980 |
| 120 | PRKACA | 0.49104950 |
| 121 | CSNK1G3 | 0.48805408 |
| 122 | IKBKB | 0.47500081 |
| 123 | PRKCD | 0.46723053 |
| 124 | CAMKK2 | 0.46576644 |
| 125 | PLK3 | 0.45852744 |
| 126 | ATM | 0.45330551 |
| 127 | CAMK2D | 0.43706510 |
| 128 | ADRBK1 | 0.43216477 |
| 129 | ROCK1 | 0.43197100 |
| 130 | STK24 | 0.43127231 |
| 131 | AURKB | 0.42982256 |
| 132 | TEC | 0.42655989 |
| 133 | PTK2B | 0.41904222 |
| 134 | VRK1 | 0.40985727 |
| 135 | TSSK6 | 0.40532000 |
| 136 | IRAK1 | 0.40231027 |
| 137 | TTK | 0.38397725 |
| 138 | CDC7 | 0.38105854 |
| 139 | AKT2 | 0.37556887 |
| 140 | FGR | 0.37139992 |
| 141 | PRKCI | 0.37013334 |
| 142 | TIE1 | 0.36997762 |
| 143 | TESK2 | 0.36102300 |
| 144 | CSNK2A1 | 0.35356567 |
| 145 | CDK19 | 0.35147225 |
| 146 | MAP3K5 | 0.34457065 |
| 147 | PRKD3 | 0.34451824 |
| 148 | STK4 | 0.33972638 |
| 149 | MUSK | 0.33251059 |
| 150 | TGFBR1 | 0.31954479 |
| 151 | CDK3 | 0.30768978 |
| 152 | CSNK2A2 | 0.30725734 |
| 153 | NLK | 0.29290611 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 4.73462206 |
| 2 | Parkinsons disease_Homo sapiens_hsa05012 | 3.81719196 |
| 3 | Alzheimers disease_Homo sapiens_hsa05010 | 2.94534374 |
| 4 | Proteasome_Homo sapiens_hsa03050 | 2.70306025 |
| 5 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.66214173 |
| 6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.62471910 |
| 7 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.61486312 |
| 8 | Huntingtons disease_Homo sapiens_hsa05016 | 2.58661430 |
| 9 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.46139082 |
| 10 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.39263381 |
| 11 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.11131396 |
| 12 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.96291693 |
| 13 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.90431375 |
| 14 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.87347357 |
| 15 | Peroxisome_Homo sapiens_hsa04146 | 1.87312613 |
| 16 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.86706541 |
| 17 | Homologous recombination_Homo sapiens_hsa03440 | 1.83738374 |
| 18 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.83735588 |
| 19 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.78895520 |
| 20 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.77021888 |
| 21 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.74901609 |
| 22 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.69862193 |
| 23 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.64378202 |
| 24 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.64251120 |
| 25 | Nicotine addiction_Homo sapiens_hsa05033 | 1.62668251 |
| 26 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.56742922 |
| 27 | Basal transcription factors_Homo sapiens_hsa03022 | 1.56207026 |
| 28 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.50176716 |
| 29 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.48732889 |
| 30 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.47550481 |
| 31 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.44188876 |
| 32 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.42429841 |
| 33 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.42225631 |
| 34 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.40258296 |
| 35 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.39748154 |
| 36 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.37810789 |
| 37 | Protein export_Homo sapiens_hsa03060 | 1.33075152 |
| 38 | RNA degradation_Homo sapiens_hsa03018 | 1.32438380 |
| 39 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.32400050 |
| 40 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.29535670 |
| 41 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.28069980 |
| 42 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.27857304 |
| 43 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.27761203 |
| 44 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.26181980 |
| 45 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.23377752 |
| 46 | Mismatch repair_Homo sapiens_hsa03430 | 1.22246942 |
| 47 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.21755322 |
| 48 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.21291310 |
| 49 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.17852493 |
| 50 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.17156048 |
| 51 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.16596042 |
| 52 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.14790718 |
| 53 | Carbon metabolism_Homo sapiens_hsa01200 | 1.14121288 |
| 54 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.13550673 |
| 55 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.13528871 |
| 56 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.12711927 |
| 57 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.10578692 |
| 58 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.09574375 |
| 59 | Histidine metabolism_Homo sapiens_hsa00340 | 1.09494959 |
| 60 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.07853118 |
| 61 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.02010709 |
| 62 | Retinol metabolism_Homo sapiens_hsa00830 | 1.00704214 |
| 63 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.00184474 |
| 64 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.99384624 |
| 65 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.97173573 |
| 66 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.95780168 |
| 67 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.94810887 |
| 68 | Phagosome_Homo sapiens_hsa04145 | 0.93166364 |
| 69 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.92851056 |
| 70 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.91064001 |
| 71 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.90774234 |
| 72 | Metabolic pathways_Homo sapiens_hsa01100 | 0.88877687 |
| 73 | Sulfur relay system_Homo sapiens_hsa04122 | 0.88576736 |
| 74 | Allograft rejection_Homo sapiens_hsa05330 | 0.88565218 |
| 75 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.86301654 |
| 76 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.86176978 |
| 77 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.86158203 |
| 78 | Ribosome_Homo sapiens_hsa03010 | 0.86115113 |
| 79 | Insulin secretion_Homo sapiens_hsa04911 | 0.84552085 |
| 80 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.83594536 |
| 81 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.78674484 |
| 82 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.77617221 |
| 83 | RNA transport_Homo sapiens_hsa03013 | 0.77591522 |
| 84 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.75356668 |
| 85 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.74786224 |
| 86 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.74760141 |
| 87 | Base excision repair_Homo sapiens_hsa03410 | 0.71293203 |
| 88 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.71241037 |
| 89 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.68451745 |
| 90 | Spliceosome_Homo sapiens_hsa03040 | 0.68153187 |
| 91 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.67837419 |
| 92 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.67008050 |
| 93 | Asthma_Homo sapiens_hsa05310 | 0.64986770 |
| 94 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.64197966 |
| 95 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.60996728 |
| 96 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.59959791 |
| 97 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.59828955 |
| 98 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.58778049 |
| 99 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.58109179 |
| 100 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.55761193 |
| 101 | Olfactory transduction_Homo sapiens_hsa04740 | 0.54562300 |
| 102 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.51453599 |
| 103 | Circadian rhythm_Homo sapiens_hsa04710 | 0.51291800 |
| 104 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.49899346 |
| 105 | Mineral absorption_Homo sapiens_hsa04978 | 0.48272167 |
| 106 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.47654964 |
| 107 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.47634828 |
| 108 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.46166272 |
| 109 | DNA replication_Homo sapiens_hsa03030 | 0.45792282 |
| 110 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.45384550 |
| 111 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.44957023 |
| 112 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.44377993 |
| 113 | GABAergic synapse_Homo sapiens_hsa04727 | 0.42478146 |
| 114 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.42452426 |
| 115 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.39417020 |
| 116 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.36309999 |
| 117 | Taste transduction_Homo sapiens_hsa04742 | 0.34879086 |
| 118 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.33394130 |
| 119 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.32977395 |
| 120 | RNA polymerase_Homo sapiens_hsa03020 | 0.31387606 |
| 121 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.31233031 |
| 122 | Legionellosis_Homo sapiens_hsa05134 | 0.30305812 |
| 123 | Morphine addiction_Homo sapiens_hsa05032 | 0.30158799 |
| 124 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.29827756 |
| 125 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.29327477 |
| 126 | Prion diseases_Homo sapiens_hsa05020 | 0.28676403 |
| 127 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.28222343 |
| 128 | Phototransduction_Homo sapiens_hsa04744 | 0.28034051 |
| 129 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.26336681 |
| 130 | Purine metabolism_Homo sapiens_hsa00230 | 0.26008459 |
| 131 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.25935522 |
| 132 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.24802577 |
| 133 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.21630832 |
| 134 | Pertussis_Homo sapiens_hsa05133 | 0.20279066 |
| 135 | Bile secretion_Homo sapiens_hsa04976 | 0.20143365 |
| 136 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.17575365 |
| 137 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.16678844 |

